Zhongyuan Union Cell & Gene Engineering (SHSE:600645) 3-Year EBITDA Growth Rate : -6.30% (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering 3-Year EBITDA Growth Rate?

Zhongyuan Union Cell & Gene Engineering's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.08.

During the past 12 months, Zhongyuan Union Cell & Gene Engineering's average EBITDA Per Share Growth Rate was -17.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -6.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 30.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zhongyuan Union Cell & Gene Engineering was 150.70% per year. The lowest was -57.60% per year. And the median was 3.45% per year.

Competitive Comparison of Zhongyuan Union Cell & Gene Engineering's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongyuan Union Cell & Gene Engineering's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Zhongyuan Union Cell & Gene Engineering 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Zhongyuan Union Cell & Gene Engineering 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongyuan Union Cell & Gene Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304

Website

http://www.vcanbio.com

Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.

Executives

Li De Fu	Director
Wang Xue Jun	senior management
Wang Yong	Director
Li Hai Bin	Director
He Wei	senior management
Li Qiang	senior management
Wu Ming Yuan	Director
Wang Hui	Director
Huang Jia Xue	senior management
Cao Hai Feng	Director
Han Yue E	Director
Liu Yong Jun	senior management
Cui Jing Xue	Supervisors
Yang Guang Xing	senior management
Meng Zhi Hong	senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines